Identification of SARS-CoV-2 entry inhibitors among already approved drugs-Reference-Cited by-同舟云学术

Identification of SARS-CoV-2 entry inhibitors among already approved drugs

Published:2020-10-28 Issue:8 Volume:42 Page:1347-1353
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Yang Li,Pei Rong-juan,Li Heng,Ma Xin-na,Zhou Yu,Zhu Feng-hua,He Pei-lan,Tang Wei,Zhang Ye-cheng,Xiong Jin,Xiao Shu-qi,Tong Xian-kun,Zhang Bo,Zuo Jian-ping

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-020-00556-6.pdf

Reference48 articles.

1. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.

2. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63:457–60.

3. Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–36.

4. Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215–20.

5. Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221–4.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a novel inhibitor of macropinocytosis with antiviral activity;Molecular Therapy;2024-09

2. The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2;mBio;2024-08-14

3. Colloidal Aggregation Confounds Cell-Based Covid-19 Antiviral Screens;Journal of Medicinal Chemistry;2024-06-12

4. High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors;iScience;2024-06

5. Exploring the Therapeutic Potential of Petiveria alliacea L. Phytochemicals: A Computational Study on Inhibiting SARS-CoV-2’s Main Protease (Mpro);Molecules;2024-05-27